Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Independent home use of a brain-computer interface by people with amyotrophic lateral sclerosis.

Wolpaw JR, Bedlack RS, Reda DJ, Ringer RJ, Banks PG, Vaughan TM, Heckman SM, McCane LM, Carmack CS, Winden S, McFarland DJ, Sellers EW, Shi H, Paine T, Higgins DS, Lo AC, Patwa HS, Hill KJ, Huang GD, Ruff RL.

Neurology. 2018 Jul 17;91(3):e258-e267. doi: 10.1212/WNL.0000000000005812. Epub 2018 Jun 27.

PMID:
29950436
2.

Refractory myasthenia gravis exacerbation triggered By pembrolizumab.

Earl DE, Loochtan AI, Bedlack RS.

Muscle Nerve. 2018 Apr;57(4):E120-E121. doi: 10.1002/mus.26021. Epub 2017 Dec 7. No abstract available.

PMID:
29193151
3.

Treatment of Thymoma-Associated Myasthenia Gravis With Stereotactic Body Radiotherapy: A Case Report.

Lee CM, Lee JD, Hobson-Webb LD, Bedlack RS, Salama JK.

Ann Intern Med. 2016 Aug 16;165(4):300-1. doi: 10.7326/L15-0469. Epub 2016 Mar 15. No abstract available.

PMID:
26974367
4.

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H; ALS COSMOS.

Neurology. 2016 Mar 1;86(9):813-20. doi: 10.1212/WNL.0000000000002305. Epub 2016 Jan 22.

5.

How common are ALS plateaus and reversals?

Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, Macklin EA, Schoenfeld D, Cudkowicz M, Sherman A.

Neurology. 2016 Mar 1;86(9):808-12. doi: 10.1212/WNL.0000000000002251. Epub 2015 Dec 9.

6.

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C.

Neurol Clin. 2015 Nov;33(4):909-36. doi: 10.1016/j.ncl.2015.07.008. Epub 2015 Sep 8. Review.

7.

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.

Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, Wimbish JR, Waite LL, Jones AL, Carulli JP, Day-Williams AG, Staropoli JF, Xin WW, Chesi A, Raphael AR, McKenna-Yasek D, Cady J, Vianney de Jong JM, Kenna KP, Smith BN, Topp S, Miller J, Gkazi A; FALS Sequencing Consortium, Al-Chalabi A, van den Berg LH, Veldink J, Silani V, Ticozzi N, Shaw CE, Baloh RH, Appel S, Simpson E, Lagier-Tourenne C, Pulst SM, Gibson S, Trojanowski JQ, Elman L, McCluskey L, Grossman M, Shneider NA, Chung WK, Ravits JM, Glass JD, Sims KB, Van Deerlin VM, Maniatis T, Hayes SD, Ordureau A, Swarup S, Landers J, Baas F, Allen AS, Bedlack RS, Harper JW, Gitler AD, Rouleau GA, Brown R, Harms MB, Cooper GM, Harris T, Myers RM, Goldstein DB.

Science. 2015 Mar 27;347(6229):1436-41. doi: 10.1126/science.aaa3650. Epub 2015 Feb 19.

8.

SAPs: a different perspective.

Rabourn J, Bedlack RS.

Am J Bioeth. 2014;14(11):19-20. doi: 10.1080/15265161.2014.957621. No abstract available.

PMID:
25325804
9.

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24.

10.

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Pastula DM, Moore DH, Bedlack RS.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD005225. doi: 10.1002/14651858.CD005225.pub3. Review.

PMID:
23235621
11.

Diaphragm pacing in amyotrophic lateral sclerosis: a literature review.

Scherer K, Bedlack RS.

Muscle Nerve. 2012 Jul;46(1):1-8. doi: 10.1002/mus.23419. Review.

PMID:
22692995
12.

Pesticide exposure and amyotrophic lateral sclerosis.

Kamel F, Umbach DM, Bedlack RS, Richards M, Watson M, Alavanja MC, Blair A, Hoppin JA, Schmidt S, Sandler DP.

Neurotoxicology. 2012 Jun;33(3):457-62. doi: 10.1016/j.neuro.2012.04.001. Epub 2012 Apr 12. Review.

13.

Compassionate use of stem cells for ALS: popovers and hot air.

Bedlack RS.

Amyotroph Lateral Scler. 2011 Sep;12(5):313-4. doi: 10.3109/17482968.2011.583743. Epub 2011 May 9. No abstract available.

PMID:
21554029
14.

Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29.

Bedlack RS, Genge A, Amato AA, Shaibani A, Jackson CE, Kissel JT, Wall C, King WM, Cupler E, Lou JS, Ensrud E, Tan E, Goldstein JM, Katz J, Dimachkie MM, Barohn RJ, Mozaffar T.

J Neuropathol Exp Neurol. 2011 Jan;70(1):96-7; author reply 98-100. doi: 10.1097/NEN.0b013e318204782b. No abstract available.

PMID:
21173608
15.

Amyotrophic lateral sclerosis: current practice and future treatments.

Bedlack RS.

Curr Opin Neurol. 2010 Oct;23(5):524-9. doi: 10.1097/WCO.0b013e32833c7ac2. Review.

PMID:
20613515
16.

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Pastula DM, Moore DH, Bedlack RS.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD005225. doi: 10.1002/14651858.CD005225.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD005225.

PMID:
20556761
17.

Modifiable barriers to enrollment in American ALS research studies.

Bedlack RS, Wicks P, Heywood J, Kasarskis E.

Amyotroph Lateral Scler. 2010 Dec;11(6):502-7. doi: 10.3109/17482968.2010.484494. Epub 2010 May 7.

PMID:
20446890
18.

Factors associated with survival in the National Registry of Veterans with ALS.

Pastula DM, Coffman CJ, Allen KD, Oddone EZ, Kasarskis EJ, Lindquist JH, Morgenlander JC, Norman BB, Rozear MP, Sams LA, Sabet A, Bedlack RS.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):332-8. doi: 10.3109/17482960802320545.

PMID:
19922120
19.

Lyme disease serology in amyotrophic lateral sclerosis.

Qureshi M, Bedlack RS, Cudkowicz ME.

Muscle Nerve. 2009 Oct;40(4):626-8. doi: 10.1002/mus.21438.

PMID:
19697382
20.

Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance.

Bedlack RS, Cudkowicz ME.

Front Neurol Neurosci. 2009;25:144-51. doi: 10.1159/000209493. Epub 2009 Mar 19. No abstract available.

PMID:
19478515

Supplemental Content

Loading ...
Support Center